The role of pro-inflammatory pathways in the pathology of psychiatric disorders
Year: 2014
Type: dissertation
Study design: Observational Study
Abstract: A rapidly increasing body of evidence substantiates the notion that abnormalities in immune system-related pathways are associated with major psychiatric disorders.A number of the studies to date have focused primarily on peripheral tissue, where it has been demonstrated that there are increased levels of soluble pro-inflammatory cytokines, including tumour necrosis factor-alpha (TNFα) in major depressive disorder (MDD), bipolar disorder (BPD) and schizophrenia.The present study investigated the levels of trans-membrane TNFα (tmTNFα) and soluble TNFα (sTNFα) using Western blots in three brain regions that are known to be assoicated with mood disorders.Postmortem brain tissue from people with MDD and BPD in Brodmann's areas (BA) 10, 24 and 46 were used.In MDD, a significant increase in tmTNFα protein levels in the BA46 brain region was observed, while in people with BPD this increase was observed in BA24.Notably, the expression of sTNFα was not altered in these subjects.The same investigations were carried out in BA24 and BA46 from people with schizophrenia and no significant difference was found in either sTNFα or tmTNFα.In an effort to establish whether the increased tmTNFα in BA24 and BA46 of people with mood disorders is reflective of an inflammatory response, levels of wellestablished protein markers of microglia and pre-synaptic neuronal cell type (synaptophysin and CD11β) were examined.The levels of interleukin-1-beta precursor (pro-IL-1β) -precursor of the major pro-inflammatory cytokine -were also investigated in people with mood disorders.Synaptophysin and CD11β levels were not altered in MDD or BPD in all regions examined, providing no evidence for changes in microglial cell numbers and pre-synaptic neuronal cell density, both of which would be expected to be changed with prolonged increased inflammatory activity.Levels of pro-IL-1β were also not altered in people with MDD or BPD providing no evidence for the recruitment of other major inflammatory mediators, which would be expected during the activation of an inflammatory response.III Also taken into consideration in this study, is the recent increased focus on serotonin 2A receptor (5-HT 2A R) agonists as a therapeutic agent in inhibiting sTNFαmediated inflammation.In light of this, a binding study was carried out using the same mood disorder cohorts and the same brain regions to investigate if increased tmTNFα accompany any alterations in 5-HT 2A R levels.The results revealed a significant reduction in 5-HT 2A R levels in BA24, but not in BA46 from people with MDD, and from individuals who died by suicide, independent of diagnosis.Importantly, it was found that increased tmTNFα is not accompanied by 5-HT 2A R alterations.A major finding of my thesis is that there are regionally specific increases in the tmTNFα protein in the cortex from people suffering from mood disorders.By contrast, no changes in tmTNFα levels were observed in people with schizophrenia.These findings suggest that the pathophysiology of mood disorders differ significantly from that of psychotic disorders.Increased tmTNFα levels in BA24 in BPD and Publications
Author: Nahed Tawadros
Institution: The University of Melbourne
Language: English
Subfield: Biological Psychiatry
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2517888982
